Pharmaceutical Technology
FEBRUARY 23, 2023
Biopharmaceutics is a scientific discipline that examines the interrelationship of the physicochemical properties of the drug, the dosage form in which the drug is given, and the route of administration on the rate and extent of systemic drug absorption ( Applied Biopharmaceutics and Pharmacokinetics, Shargel, Wu-Pong and Yu, 5th Edition ).
Bio Pharma Dive
FEBRUARY 21, 2023
There comes a time when companies with platforms need to focus on their most advanced prospects, Morrison said, rather than sink all of their funds into building the technology
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
FEBRUARY 20, 2023
By Jeffrey N. Wasserstein — GoodRx is a digital health platform familiar to many, and a prime example of a single player that operates in several different realms of the evolving and growing digital health marketplace.
Fierce Pharma
FEBRUARY 24, 2023
Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license esagonowsky Fri, 02/24/2023 - 09:18
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.
Pharmaceutical Technology
FEBRUARY 24, 2023
On December 20, 2022, the World Health Organization (WHO) updated its recommendations for cervical cancer vaccines in a bid to boost vaccination coverage.
Bio Pharma Dive
FEBRUARY 21, 2023
The proposed model could help state Medicaid agencies explore different kinds of outcomes-based payment schemes, but may come too late to prepare for the first sickle cell gene therapy
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Intouch Solutions
FEBRUARY 20, 2023
EVERSANA INTOUCH is once again celebrating Black History Month this February!
Pharmaceutical Technology
FEBRUARY 23, 2023
Biohacking is a do-it-yourself biology movement that aims to improve the hacker’s health, appearance, performance, and overall well-being.
Bio Pharma Dive
FEBRUARY 21, 2023
Many current top-selling products will lose patent protection by the end of the decade, putting pressure on companies to replace lost revenue with new medicines
Pharma Marketing Network
FEBRUARY 22, 2023
Marketing in the era of consumer-driven healthcare requires new tools and techniques. If you want patients to initiate therapy, you need to connect across more channels, more personally, and in the ways consumers prefer to be engaged.
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
Pharma Times
FEBRUARY 21, 2023
Boost for effected patients as HEMGENIX receives green light from European Commission
Pharmaceutical Technology
FEBRUARY 23, 2023
GenScript ProBio has announced a strategic collaboration with RVAC Medicines to manufacture GMP-grade plasmid DNA (pDNA) for the latter’s RVM-V001, an mRNA Covid-19 vaccine candidate. Under the agreement, GenScript ProBio will offer GMP plasmid manufacturing service for the RVM-V001 programme.
Bio Pharma Dive
FEBRUARY 23, 2023
Sanofi and its development partner, Sobi, claim the drug’s once-a-week dosing, and its effect on blood-clotting protein levels, will help it compete in the crowded market for hemophilia A treatments
BioPharma Reporter
FEBRUARY 21, 2023
The Danish-US biotech Hemab Therapeutics bags $135m to finance the clinical development of prophylactic treatments for genetic bleeding disorders including Glanzmann thrombasthenia and von Willebrand disease. Bio Developments
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
Pharma Times
FEBRUARY 23, 2023
Phase 1/2 research shows that treatment could be very effective against Fabry disease
Pharmaceutical Technology
FEBRUARY 22, 2023
Amgen could be the winner of a high-stakes patent spat with Sanofi as tensions run high weeks before the March 27 US Supreme Court hearing. While some courts were previously on Sanofi’s side, it is possible that Amgen’s case could win this time, some legal experts say.
Bio Pharma Dive
FEBRUARY 23, 2023
Eisai and Biogen have data showing Leqembi slows cognitive decline, but CMS won’t budge until FDA converts its approval from accelerated to full
Outsourcing Pharma
FEBRUARY 22, 2023
Patient engagement, recruitment and retention are critical to achieving a successful clinical trial. Patient centricity
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
Pharma Times
FEBRUARY 23, 2023
Next phase of Newel Health’s digital therapeutics solution for Parkinson’s disease gains vital grant
Pharmaceutical Technology
FEBRUARY 22, 2023
The US Food and Drug Administration (FDA) has granted Fast Track designation for Biohaven ’s new anti-myostatin adnectin, taldefgrobep alfa, to treat spinal muscular atrophy (SMA).
Bio Pharma Dive
FEBRUARY 23, 2023
Graphite Bio and Sangamo are stopping work on their respective sickle cell gene therapies, while Intellia revealed partner Novartis ended development of its genetic treatment for the blood disease
Fierce Pharma
FEBRUARY 24, 2023
Merck's COVID pill Lagevrio takes another hit with thumbs-down from EU regulator kdunleavy Fri, 02/24/2023 - 09:38
Pharma Times
FEBRUARY 24, 2023
Africa-based trials for blood test which detects risk of disease progression are due to begin
Pharmaceutical Technology
FEBRUARY 21, 2023
Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, had a phenomenal year with forecast sales of $37bn in 2022.
Bio Pharma Dive
FEBRUARY 22, 2023
The messenger RNA specialist said Wednesday it is teaming up with Life Edit Therapeutics to develop therapies that can modify genes “in vivo &rdquo
Fierce Pharma
FEBRUARY 23, 2023
Sanofi, poised to rival Roche in hemophilia, nabs FDA approval for Altuviiio zbecker Thu, 02/23/2023 - 15:45
Pharma Times
FEBRUARY 22, 2023
Research will analyse how Huawei’s wearable technology detects atrial fibrillation in post-stroke patients
Pharmaceutical Technology
FEBRUARY 20, 2023
The US Food and Drug Administration (FDA) has granted approval for Apellis Pharmaceuticals’ Syfovre (pegcetacoplan injection) to treat geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD).
Bio Pharma Dive
FEBRUARY 24, 2023
Weeks after the Swiss drugmaker wrote off Gavreto’s accounting value, the biotech will regain responsibility for its commercialization
BioSpace
FEBRUARY 23, 2023
Reata, Friedreich’s Ataxia Patients Await Potential First Approval 2/24/2023
Pharma Times
FEBRUARY 20, 2023
Research concerns the effect of niraparib when combined with abiraterone acetate plus prednisone
Pharmaceutical Technology
FEBRUARY 20, 2023
Many have turned their attention to frontotemporal dementia (FTD) as the family of famed action star Bruce Willis announced his diagnosis last week.
Bio Pharma Dive
FEBRUARY 21, 2023
Real-world data and advanced analytics reveal patterns and insights into why patients stop therapies
Expert insights. Personalized for you.
246 
Let's personalize your content